세계의 바이오 촉매 시장 보고서 : 유형, 용도, 공급원, 지역별(2025-2033년)

The global biocatalyst market size reached 155.0 Kilo Tons in 2024. Looking forward, IMARC Group expects the market to reach 234.5 Kilo Tons by 2033, exhibiting a growth rate (CAGR) of 4.7% during 2025-2033. The market is experiencing steady growth driven by the increasing awareness among the masses about environmental issues and need for sustainable practices across industries, rising adoption in pharmaceutical and healthcare industries, and the escalating demand for biofuels around the world.

Biocatalyst Market Analysis:

Market Growth and Size: The market is witnessing stable growth, which can be attributed to the increasing demand for sustainable and eco-friendly solutions. In addition, the growing awareness among the masses about environmental concerns and the need for green alternatives is positively influencing the market.

Technological Advancements: Continuous research and development (R&D) activities are leading to improved biocatalyst formulations, enhancing their efficiency and stability. Moreover, enzyme engineering techniques are paving the way for tailored biocatalysts for specific applications.

Industry Applications: Biocatalysts find applications across various industries, including chemical, pharmaceuticals, food and beverage (F&B), and agriculture. Besides this, enzymes are widely used in pharmaceutical synthesis and biodegradable product manufacturing.

Geographical Trends: North America leads the market, on account of its thriving biotechnology industry and stringent environmental regulations. However, Europe is emerging as a fast-growing market, driven by strong government support for sustainable practices and green technologies.

Competitive Landscape: Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are also expanding their production capacities and enhancing their supply chain to meet the growing demand for biocatalysts.

Challenges and Opportunities: While the market faces challenges, such as regulatory hurdles and the need for optimizing biocatalyst production processes, it also encounters opportunities in expanding applications, such as in the bio-based chemicals applications.

Future Outlook: The future of the biocatalyst market looks promising, with sustainability initiatives and innovation. As industries are seeking greener solutions, biocatalysts will remain a critical component of their strategies, which is expected to propel the market growth.

Biocatalyst Market Trends:

Growing environmental awareness and sustainability concerns

The increasing awareness among the masses about environmental issues and need for sustainable practices across industries is strengthening the growth of the market. With rising concerns about climate change, pollution, and resource depletion, there is a growing emphasis on adopting eco-friendly solutions in various sectors. Biocatalysts, which are derived from natural sources like enzymes, align perfectly with this sustainability drive. They offer a green alternative to traditional chemical processes, significantly reducing the environmental footprint. Biocatalysis not only reduces hazardous waste production but also conserves energy and raw materials, making it an attractive choice for industries seeking to minimize their impact on the planet. As regulations are becoming stricter and there is a rise in the demand for eco-conscious products, the adoption of biocatalysts is increasing around the world.

Increasing adoption in pharmaceutical and healthcare industries

The rising adoption of biocatalysts in the pharmaceutical and healthcare sectors is propelling the growth of the market. Biocatalysts, particularly enzymes, play a pivotal role in pharmaceutical synthesis and drug manufacturing processes. They offer numerous advantages, such as high specificity, selectivity, and reduced environmental impact compared to traditional chemical methods. Enzymatic reactions enable the production of pharmaceuticals with higher purity and fewer by-products, resulting in cost savings and improved product quality. Moreover, biocatalysts are essential in the synthesis of chiral compounds, a critical component in many drug formulations. As the pharmaceutical industry is expanding and focusing on biopharmaceuticals, the demand for biocatalysts is rising. This trend highlights the crucial role of biocatalysts in advancing healthcare solutions and drug development.

Biofuels and renewable energy initiatives

The increasing demand for biofuels and the global shift towards renewable energy sources is supporting the growth of the market. Biocatalysts, particularly enzymes, are vital components in the production of biofuels, such as biodiesel and bioethanol. They facilitate the conversion of biomass and agricultural feedstocks into sustainable and clean energy alternatives. As several countries are focusing on reducing greenhouse gas emissions and combating climate change, biofuels are gaining traction as a greener substitute for fossil fuels. Biocatalysts not only enhance the efficiency of biofuel production but also make it more economically viable. Governments and industries worldwide are investing in renewable energy initiatives and adopting biofuels to meet sustainability targets, thereby catalyzing the demand for biocatalysts.

Expanding applications in the food and beverage (F&B) industry

Biocatalysts, especially enzymes, are utilized in food processing, production, and quality enhancement. Enzymes play a crucial role in various aspects of food production, including starch conversion, dairy product manufacturing, brewing, and flavor modification. They enable more precise control over processes, resulting in improved product consistency and quality. Moreover, biocatalysts offer advantages like reduced processing time and resource efficiency, making them cost-effective solutions for food manufacturers. As consumer preferences are shifting towards natural and clean-label food products, biocatalysts are favored for their ability to replace chemical additives and enhance the sustainability of food production. This growing acceptance of biocatalysts in the food and beverage (F&B) industry is offering a favorable market outlook.

Biocatalyst Industry Segmentation:

Breakup by Type:

• Hydrolases
• Oxidoreductases
• Transferases
• Others

Hydrolases account for the majority of the market share

Hydrolases are characterized by their ability to catalyze the cleavage of chemical bonds by adding water molecules. They find extensive applications in various industries, including pharmaceuticals and food and beverage (F&B). In pharmaceuticals, hydrolases play a critical role in drug synthesis, aiding in the production of active pharmaceutical ingredients (APIs) and intermediates with high purity and yield. Moreover, they are used in the food and beverage (F&B) industry to improve flavor, texture, and shelf life of products, making them a cornerstone of enzymatic processes.

The oxidoreductases segment holds a significant share in the market. These enzymes are involved in oxidation-reduction reactions, where electrons are transferred between molecules. Oxidoreductases have vital applications in biofuel production, pharmaceuticals, and chemical synthesis. They play a crucial role in converting biomass into bioethanol and biodiesel, contributing to the growing demand for sustainable energy sources. Additionally, oxidoreductases are used in the pharmaceutical sector for synthesizing chiral compounds and in chemical manufacturing processes to produce fine chemicals. Their unique ability to facilitate redox reactions positions them as essential components in biocatalysis, driving their market presence.

The transferases segment represents an important category within the market. These enzymes are involved in transferring functional groups from one molecule to another, making them indispensable in several applications. They also play a pivotal role in catalyzing reactions to produce specific compounds, such as in the synthesis of nucleic acids and glycosides in pharmaceutical manufacturing. Additionally, transferases find applications in bioconjugation and bioengineering, enabling the modification and functionalization of biomolecules for various purposes.

Breakup by Application

• Food and Beverages
• Cleaning Agent
• Biofuel Production
• Agriculture and Feed
• Biopharmaceuticals
• Others

Food and beverages hold the largest share in the industry

Biocatalysts are used in cleaning agents, such as detergents and industrial cleaners. Enzymes like proteases and lipases are employed to break down complex organic stains and soils effectively. This environment-friendly approach not only improves cleaning efficiency but also reduces the environmental impact of cleaning products by lowering the need for harsh chemicals. The cleaning agent segment is witnessing growth as consumers and industries are shifting towards sustainable and eco-friendly cleaning solutions.

The biofuel production segment is a significant application area for biocatalysts, particularly in the context of bioethanol and biodiesel production. Enzymes play a crucial role in breaking down biomass into fermentable sugars and converting triglycerides into biodiesel. With the global emphasis on reducing greenhouse gas emissions and transitioning to renewable energy sources, the biofuel production segment is expected to expand, thereby catalyzing the demand for biocatalysts.

Biocatalysts also find applications in agriculture and animal feed industries. Enzymes are used to improve the digestibility of animal feed, enhancing nutrient absorption in livestock. In agriculture, biocatalysts aid in soil remediation and crop protection by facilitating the breakdown of organic matter and pesticides. As sustainable farming practices are gaining traction, there is a rise in the demand for biocatalyst around the world.

The biopharmaceuticals segment utilizes biocatalysts in the production of pharmaceuticals and biologics. Enzymes are essential for the synthesis of complex molecules, including biopharmaceuticals, such as monoclonal antibodies and vaccines. Their role in enabling precise and efficient chemical transformations makes biocatalysts valuable tools in biopharmaceutical manufacturing, contributing to the growth of this segment in the market.

Breakup by Source:

• Microorganisms
• Plants
• Animal

Microorganisms represent the leading market segment

Plants serve as another source of biocatalysts, albeit to a lesser extent compared to microorganisms. Enzymes extracted from plants find applications in sectors like agriculture, horticulture, and cosmetics. Plant-derived proteases are used in the formulation of plant-based cleaning agents and skincare products. While plants may offer specific enzymes for certain applications, their usage is relatively niche compared to microorganisms due to challenges in enzyme extraction and limited scalability.

Enzymes from animal sources, such as digestive enzymes like pepsin, are used in specific pharmaceutical and food applications. However, their usage is restricted due to ethical and regulatory concerns regarding animal-derived products. Furthermore, the development of alternatives from microbial sources has limited the growth potential of this segment. Nevertheless, certain specialized enzymes sourced from animals continue to find niche applications in the market, particularly in pharmaceuticals and research.

Breakup by Region:

• Europe
• North America
• Asia-Pacific
• Latin America
• Middle East and Africa

North America leads the market, accounting for the largest biocatalyst market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America dominates the market share on account of its thriving biotechnology industry, significant research and development (R&D) activities, and stringent environmental regulations that encourage the adoption of sustainable and green technologies. Biocatalysts are extensively used in pharmaceuticals, biofuels, and various other industries in the North America region, contributing to the market growth.

Europe is another prominent market for biocatalysts, characterized by strong government support for sustainable practices and green technologies. Countries like Germany, the Netherlands, and the United Kingdom are at the forefront of biocatalyst research activities. Besides this, stringent environmental regulations are encouraging industries to shift towards cleaner and more eco-friendly processes, catalyzing the demand for biocatalysts across sectors.

The Asia Pacific region is witnessing rapid growth in the market, driven by growing population, industrialization, and a rising awareness of sustainability. Additionally, the pharmaceutical and food and beverage (F&B) sectors in the Asia Pacific region are expanding, creating substantial opportunities for biocatalyst applications.

Latin America is an emerging market as countries like Brazil and Argentina are showing increasing interest in green technologies. Moreover, the growing utilization of biocatalyst in the agriculture industry is offering a favorable market outlook in the region.

The Middle East and Africa represent a smaller segment of the market.As industries are seeking to reduce their environmental footprint and diversify their economies, there is a rise in the demand for biocatalyst in the region.

Leading Key Players in the Biocatalyst Industry:

Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are investing in R&D activities to innovate and optimize biocatalysts for various applications. Additionally, these companies are expanding their production capacities and enhancing their supply chain to meet the growing demand for biocatalysts, especially in industries like pharmaceuticals. Many key players are also focusing on sustainability by developing eco-friendly biocatalysts and promoting their use in green processes. Collaborations and partnerships with research institutions and industrial players are fostering innovation and market penetration. Furthermore, these companies are closely monitoring regulatory changes and compliance to ensure their products meet evolving environmental standards.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Novozymes A/S
• DuPont de Nemours Inc.
• Koninklijke DSM N.V.

Key Questions Answered in This Report

• 1.What was the size of the global biocatalyst market in 2024?
• 2.
• What is the expected growth rate of the global biocatalyst market during 2025-2033?
• 3.What are the key factors driving the global biocatalyst market?
• 4.What has been the impact of COVID-19 on the global biocatalyst market?
• 5.What is the breakup of the global biocatalyst market based on the type?
• 6.What is the breakup of the global biocatalyst market based on the application?
• 7.What is the breakup of the global biocatalyst market based on the source?
• 8.What are the key regions in the global biocatalyst market?
• 9.Who are the key players/companies in the global biocatalyst market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Biocatalyst Market

• 5.1 Market Overview
• 5.2 Market Performance
  • 5.2.1 Volume Trends
  • 5.2.2 Value Trends
• 5.3 Impact of COVID-19
• 5.4 Price Analysis
  • 5.4.1 Key Price Indicators
  • 5.4.2 Price Structure
  • 5.4.3 Price Trends
• 5.5 Market Breakup by Type
• 5.6 Market Breakup by Region
• 5.7 Market Breakup by Application
• 5.8 Market Breakup by Source
• 5.9 Market Forecast
• 5.10 SWOT Analysis
  • 5.10.1 Overview
  • 5.10.2 Strengths
  • 5.10.3 Weaknesses
  • 5.10.4 Opportunities
  • 5.10.5 Threats
• 5.11 Value Chain Analysis
  • 5.11.1 Raw Material Procurement
  • 5.11.2 Manufacturing
  • 5.11.3 Marketing
  • 5.11.4 Distribution
  • 5.11.5 Exports
  • 5.11.6 End-Use
• 5.12 Porter's Five Forces Analysis
  • 5.12.1 Overview
  • 5.12.2 Bargaining Power of Buyers
  • 5.12.3 Bargaining Power of Suppliers
  • 5.12.4 Degree of Competition
  • 5.12.5 Threat of New Entrants
  • 5.12.6 Threat of Substitutes
• 5.13 Key Market Drivers and Success Factors

6 Market Breakup by Type

• 6.1 Hydrolases
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Oxidoreductases
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Transferases
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Region

• 7.1 Europe
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 North America
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Asia-Pacific
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Latin America
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Middle East and Africa
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Food and Beverages
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Cleaning Agent
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Biofuel Production
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Agriculture and Feed
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Biopharmaceuticals
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Source

• 9.1 Microorganisms
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Plants
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Animal
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Competitive Landscape

• 10.1 Competitive Structure
• 10.2 Market Share of Key Players

11 Key Players

• 11.1 Novozymes A/S
• 11.2 DuPont de Nemours Inc.
• 11.3 Koninklijke DSM N.V.